A retrospective study on the efficacy and safety of donafenib combined with transarterial chemoembolization (TACE) and with/without immunotherapy in intermediate-advanced hepatocellular carcinoma (HCC).

被引:0
|
作者
Chen, Cong
Fu, Shouzhong
Zhao, Suming
Yuan, Hongxin
Dai, Feng
Gu, Weiwei
Gu, Zhuxin
Shi, Rongfeng
Yang, Xiaohu
Lu, Xiaohua
Jia, Pengfei
Si, Luyi
Zhao, Hui
机构
[1] Affiliated Hosp Nantong Univ, Nantong, Peoples R China
[2] Nantong Univ, Nantong Peoples Hosp 3, Nantong, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16171
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Transarterial chemoembolization (TACE) with degradable starch microspheres (DSM) in hepatocellular carcinoma (HCC): multi-center results on safety and efficacy
    Schicho, Andreas
    Pereira, Philippe L.
    Haimerl, Michael
    Niessen, Christoph
    Michalik, Katharina
    Beyer, Lukas P.
    Stroszczynski, Christian
    Wiggermann, Philipp
    ONCOTARGET, 2017, 8 (42) : 72613 - 72620
  • [42] Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
    Zheng, Liyun
    Fang, Shiji
    Wu, Fazong
    Chen, Weiqian
    Chen, Minjiang
    Weng, Qiaoyou
    Wu, Xulu
    Song, Jingjing
    Zhao, Zhongwei
    Ji, Jiansong
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 7
  • [43] Therapeutic approaches in intermediate-stage hepatocellular carcinoma (HCC): a novel insight of adjuvant transarterial chemoembolization (TACE)
    Fernandez-Palanca, Paula
    Mauriz, Jose L.
    CHINESE CLINICAL ONCOLOGY, 2023, 12 (02)
  • [44] Efficacy and safety of transarterial therapy combined with donafenib plus immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A multicenter retrospective study.
    Shang, Changzhen
    Zhong, Jinyi
    Luo, Xuan
    Zhang, Bo
    Chen, Huanwei
    Wang, Fengjie
    Jiang, Xiaofeng
    Cao, Liangqi
    Shen, Shun-Li
    Chen, Yajin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] Efficacy and Safety of Transarterial Chemoembolization in Elderly Patients of Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Study
    Tang, Qinghe
    Huang, Wei
    Liang, Jun
    Xue, Junli
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] Comparing the efficacy and safety of TACE combined with donafenib or lenvatinib in the treatment of unresectable hepatocellular carcinoma.
    Wei, Ning
    Lu, Dong
    Zhou, Chunze
    Cheng, Delei
    Zhang, Zhengfeng
    Zhang, Xingming
    Xiao, Jingkun
    Lv, Weifu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
    Shao, Wenbo
    Zhang, Fengjuan
    Cong, Ning
    Li, Jinpeng
    Song, Jinlong
    ONCOLOGY LETTERS, 2014, 8 (05) : 2263 - 2266
  • [48] Transarterial Chemoembolization (TACE) plus Sorafenib Versus TACE for Intermediate or Advanced Stage Hepatocellular Carcinoma: A Meta-Analysis
    Zhang, Leida
    Hu, Peng
    Chen, Xi
    Bie, Ping
    PLOS ONE, 2014, 9 (06):
  • [49] Efficacy and safety analysis of transarterial chemoembolization and transarterial radioembolization in advanced hepatocellular carcinoma descending hepatectomy
    Feng, Rui
    Cheng, De-Xin
    Song, Tao
    Chen, Long
    Lu, Kai-Ping
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 15 (04): : 687 - 697
  • [50] Efficacy of Transarterial Chemoembolization (TACE) for Early-Stage Hepatocellular Carcinoma
    Lee, Moonhyung
    Shin, Hyun Phil
    MEDICINA-LITHUANIA, 2023, 59 (12):